Clinical Safety of a New Infant Starter Formula Containing 2 Human Milk Oligosaccharides (HMOs)

Inclusion Criteria: * Healthy babies * Full term babies (37 weeks ≤ gestation ≤ 42 weeks) * birth weight between 2500 g- 4500g * Having obtained the baby's legal representative's informed consent. * FF groups: babies aged between birth and 14 days, exclusively formula-fed at time of enrollment, whose mother independently elected, before enrollment, not to breastfeed • BF group: babies aged 3 months (+/- 5 days), exclusively breastfed since birth. Exclusion Criteria: * Congenital illness or malformation that may affect growth * Significant pre-natal and/or serious post-natal disease before enrollment (by medical decision) * Minor parent(s) * Newborn whose parents / caregivers cannot be expected to comply with study procedures * Currently participating or having participated in another clinical trial since birth, except for BF group, where vaccines studies are allowed.